Protocol for a multi-phase, mixed methods study to develop and evaluate culturally adapted CBT to improve community mental health services for Canadians of south Asian origin.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
06 Sep 2021
Historique:
received: 07 01 2021
accepted: 17 08 2021
entrez: 7 9 2021
pubmed: 8 9 2021
medline: 9 9 2021
Statut: epublish

Résumé

Canadians of South Asian (SA) origin comprise the largest racialized group in Canada, representing 25.6% of what Statistics Canada terms "visible minority populations". South Asian Canadians are disproportionately impacted by the social determinants of health, and this can result in high rates of mood and anxiety disorders. These factors can negatively impact mental health and decrease access to care, thereby increasing mental health inequities. Cognitive Behavioural Therapy (CBT) in its current form is not suitable for persons from the non-western cultural backgrounds. Culturally adapted Cognitive Behavioural Therapy (CaCBT) is an evidence-based practice. CaCBT is more effective than standard CBT and can reduce dropouts from therapy compared with standard CBT. Thus, CaCBT can increase access to mental health services and improve outcomes for immigrant, refugee and ethno-cultural and racialized populations. Adapting CBT for growing SA populations in Canada will ensure equitable access to effective and culturally appropriate interventions. The primary aim of the study is to develop and evaluate CaCBT for Canadian South Asian persons with depression and anxiety and to gather data from stakeholders to develop guidelines to culturally adapt CBT. This mixed methods study will use three phases: (1) cultural adaptation of CBT, (2) pilot feasibility of CaCBT and (3) implementation and evaluation of CaCBT. Phase 1 will use purposive sampling to recruit individuals from four different groups: (1) SA patients with depression and anxiety, (b) caregivers and family members of individuals affected by anxiety and depression, (c) mental health professionals and (d) SA community opinion leaders. Semi-structured interviews will be conducted virtually and analysis of interviews will be informed by an ethnographic approach. Phase 2 will pilot test the newly developed CaCBT for feasibility, acceptability and effectiveness via quantitative methodology and a randomized controlled trial, including an economic analysis. Phase 3 will recruit therapists to train and evaluate them in the new CaCBT. The outcome of this trial will benefit health services in Canada, in terms of helping to reduce the burden of depression and anxiety and provide better care for South Asians. We expect the results to help guide the development of better services and tailor existing services to the needs of other vulnerable groups. ClinicalTrials.gov NCT04010890. Registered on July 8, 2019.

Sections du résumé

BACKGROUND BACKGROUND
Canadians of South Asian (SA) origin comprise the largest racialized group in Canada, representing 25.6% of what Statistics Canada terms "visible minority populations". South Asian Canadians are disproportionately impacted by the social determinants of health, and this can result in high rates of mood and anxiety disorders. These factors can negatively impact mental health and decrease access to care, thereby increasing mental health inequities. Cognitive Behavioural Therapy (CBT) in its current form is not suitable for persons from the non-western cultural backgrounds. Culturally adapted Cognitive Behavioural Therapy (CaCBT) is an evidence-based practice. CaCBT is more effective than standard CBT and can reduce dropouts from therapy compared with standard CBT. Thus, CaCBT can increase access to mental health services and improve outcomes for immigrant, refugee and ethno-cultural and racialized populations. Adapting CBT for growing SA populations in Canada will ensure equitable access to effective and culturally appropriate interventions.
METHODS METHODS
The primary aim of the study is to develop and evaluate CaCBT for Canadian South Asian persons with depression and anxiety and to gather data from stakeholders to develop guidelines to culturally adapt CBT. This mixed methods study will use three phases: (1) cultural adaptation of CBT, (2) pilot feasibility of CaCBT and (3) implementation and evaluation of CaCBT. Phase 1 will use purposive sampling to recruit individuals from four different groups: (1) SA patients with depression and anxiety, (b) caregivers and family members of individuals affected by anxiety and depression, (c) mental health professionals and (d) SA community opinion leaders. Semi-structured interviews will be conducted virtually and analysis of interviews will be informed by an ethnographic approach. Phase 2 will pilot test the newly developed CaCBT for feasibility, acceptability and effectiveness via quantitative methodology and a randomized controlled trial, including an economic analysis. Phase 3 will recruit therapists to train and evaluate them in the new CaCBT.
DISCUSSION CONCLUSIONS
The outcome of this trial will benefit health services in Canada, in terms of helping to reduce the burden of depression and anxiety and provide better care for South Asians. We expect the results to help guide the development of better services and tailor existing services to the needs of other vulnerable groups.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT04010890. Registered on July 8, 2019.

Identifiants

pubmed: 34488853
doi: 10.1186/s13063-021-05547-4
pii: 10.1186/s13063-021-05547-4
pmc: PMC8419942
doi:

Banques de données

ClinicalTrials.gov
['NCT04010890']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

600

Subventions

Organisme : Health Canada
ID : 1920-HQ-000037

Informations de copyright

© 2021. The Author(s).

Références

Psychiatr Serv. 2017 Sep 1;68(9):899-906
pubmed: 28502247
J Ment Health Policy Econ. 2015 Sep;18(3):147-55
pubmed: 26474050
J Clin Psychiatry. 2016 Sep;77(9):e1108-e1116
pubmed: 27487160
Br J Psychiatry. 1991 Mar;158:379-86
pubmed: 2036538
J Consult Clin Psychol. 2001 Jun;69(3):502-10
pubmed: 11495179
J Affect Disord. 2015 May 15;177:101-7
pubmed: 25766269
BMC Psychiatry. 2014 May 26;14:154
pubmed: 24884792
Br Dent J. 2008 Mar 22;204(6):291-5
pubmed: 18356873
Biometrics. 2019 Dec;75(4):1391-1400
pubmed: 31009064
Ann Intern Med. 2008 Feb 19;148(4):295-309
pubmed: 18283207
J Ment Health Policy Econ. 2006 Dec;9(4):201-7
pubmed: 17200597
JAMA. 2004 Jun 2;291(21):2581-90
pubmed: 15173149
BMC Psychiatry. 2017 Apr 8;17(1):131
pubmed: 28390407
J Psychiatr Pract. 2016 Jan;22(1):2-8
pubmed: 26813483
J Cross Cult Gerontol. 2008 Mar;23(1):57-75
pubmed: 17990088
Soc Psychiatry Psychiatr Epidemiol. 2008 Nov;43(11):866-71
pubmed: 18500481
BMJ. 2014 Dec 16;349:g7636
pubmed: 25515819
Behav Cogn Psychother. 2014 Nov;42(6):693-705
pubmed: 23867053
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Can J Psychiatry. 2003 Apr;48(3):161-70
pubmed: 12728740
Schizophr Res. 2015 May;164(1-3):143-8
pubmed: 25757714
Psychiatr Serv. 2015 Oct;66(10):1035-42
pubmed: 26129996
Community Ment Health J. 2002 Dec;38(6):497-504
pubmed: 12474937
Am J Geriatr Psychiatry. 2013 Jun;21(6):536-48
pubmed: 23567409
Qual Health Res. 2012 Aug;22(8):1083-93
pubmed: 22707343
Br J Psychiatry Suppl. 2000;(39):s41-8
pubmed: 10945077
Behav Cogn Psychother. 2016 Jan;44(1):43-55
pubmed: 25180541

Auteurs

Farooq Naeem (F)

Department of Psychiatry, University of Toronto, Toronto, Canada. farooqnaeem@yahoo.com.
Centre for Addiction and Mental Health, 33 Ursula Franklin St., Toronto, Ontario, M5S 2S1, Canada. farooqnaeem@yahoo.com.

Andrew Tuck (A)

Centre for Addiction and Mental Health, 33 Ursula Franklin St., Toronto, Ontario, M5S 2S1, Canada.

Baldev Mutta (B)

Punjabi Community Health Services, Toronto, Canada.

Puneet Dhillon (P)

Punjabi Community Health Services, Toronto, Canada.

Gary Thandi (G)

Moving Forward Family Services, Vancouver, Canada.

Azaad Kassam (A)

University of Ottawa, Ottawa, Canada.

Nimo Farah (N)

Somerset West Community Health Centre, Ottawa, Canada.

Aamna Ashraf (A)

Centre for Addiction and Mental Health, 33 Ursula Franklin St., Toronto, Ontario, M5S 2S1, Canada.

M Ishrat Husain (MI)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Centre for Addiction and Mental Health, 33 Ursula Franklin St., Toronto, Ontario, M5S 2S1, Canada.

M Omair Husain (MO)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Centre for Addiction and Mental Health, 33 Ursula Franklin St., Toronto, Ontario, M5S 2S1, Canada.

Helen-Maria Vasiliadis (HM)

Department of Community Health Sciences, Faculty of Medicine and Health Science, Université de Sherbrooke, Research Center Charles-Le Moyne - Saguenay-Lac-Saint-Jean sur les innovations en santé, Montreal, Canada.

Marcos Sanches (M)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Centre for Addiction and Mental Health, 33 Ursula Franklin St., Toronto, Ontario, M5S 2S1, Canada.

Tariq Munshi (T)

Department of Psychiatry, University of Toronto, Toronto, Canada.
St Michael's Hospital, Toronto, Canada.

Maureen Abbott (M)

Mental Health Commission of Canada, Ottawa, Canada.

Nicholas Watters (N)

Mental Health Commission of Canada, Ottawa, Canada.

Sean A Kidd (SA)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Centre for Addiction and Mental Health, 33 Ursula Franklin St., Toronto, Ontario, M5S 2S1, Canada.

Muhammad Ayub (M)

Queen's University, Kingston, Canada.

Kwame McKenzie (K)

Department of Psychiatry, University of Toronto, Toronto, Canada.
Centre for Addiction and Mental Health, 33 Ursula Franklin St., Toronto, Ontario, M5S 2S1, Canada.
Wellesley Institute, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH